Please assess the completion status of the following clinical trial:

Trial Title: Use of AEEG as Predictor of Long-term Motor Outcome in Neonates With Congenital Heart Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Newborn with cardiac anomaly requiring surgical intervention or a newborn that is in NICU for at least 24 hours for monitoring~* If newborn has congenital cardiac anomaly, cardiac repair must be performed at Mount Sinai Hospital~* If newborn has congenital cardiac anomaly, he/she must be managed pre-operatively for at least 24 hours at Mount Sinai Hospital~* If newborn has congenital cardiac anomaly, he/she must be managed post-operatively at Mount Sinai Hospital for at least 72 hours~Exclusion Criteria:~* Newborns with previously known anomalies other than cardiac~* Chromosomal abnormalities other than 22Q, that might have long-term neurodevelopmental implications~* Diagnosis of hypoxic-ischemic encephalopathy~* Metabolic disorder~* Other genetic disorders

- Gender: ALL
- Minimum Age: 1 Day
- Maximum Age: 2 Months
- Healthy Volunteers: f

Study Arms:
- Neonates with congenital heart disease (Type: None): The case group will consist of newborns born between 32 and 41 weeks gestation diagnosed with a congenital cardiac anomaly requiring surgical repair during their hospitalization and managed in the Mount Sinai Neonatal Intensive Care Unit. The control arm will include newborns born between 32 and 41 weeks without congenital cardiac anomalies. Both groups will undergo a neurological screening assessment and receive an AEEG to look at sleep wake cycles.

Based on this trial design, predict the completion outcome and termination type (if applicable).